US 10,017,453 B2Granted

Pharmaceutically acceptable salts of fatty acids

AssigneeDS Biopharma Limited

InventorsMehar Manku, David Coughlan, Bill Downes

Life of this patent

Estimating the term…

Abstract

The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same.

Claims5

Dependent claims

A lysine salt form of 15-hydroxy-8(Z),11(Z),13(E)-eicosatrienoic acid (15-HETrE).

Dependencies are inferred from the claim text.

Facts

Application: 14/543,638Filed 17 Nov 2014 · us provisional application
Priority: 15 Nov 2013
Published: US 2015/0152034 A14 Jun 2015
Granted: 10 Jul 2018
Term ends: Not estimatedThe source records don’t support an estimate.

Classification19 codes

C07C 229/26
The carbon skeleton being acyclic and saturated: having more than one amino group bound to the carbon skeleton, e.g. lysine
A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 1/18
Drugs for disorders of the alimentary tract or the digestive system: for pancreatic disorders, e.g. pancreatic enzymes

Family

Application61/904,600Us provisional application · filed 15 Nov 2013
US 2015/0152034 A1Pre-grant publication · published 4 Jun 2015
US 10,017,453 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results